---
layout: minimal-medicine
nav_exclude: true
title: Dabrafenib
---

# Dabrafenib

**Generic Name:** Dabrafenib

**Usage:** Dabrafenib is a targeted therapy used to treat certain types of cancer that have a specific genetic mutation called BRAF V600E or V600K.  These mutations are commonly found in:

* **Melanoma:**  This is the most common use of dabrafenib, particularly in advanced or metastatic melanoma.
* **Non-small cell lung cancer (NSCLC):**  Used in specific NSCLC subtypes with the BRAF V600E or V600K mutation.
* **Other cancers:** It may be used in other cancers harboring the BRAF V600 mutation, though less frequently.  Use in these cancers is often based on clinical trials and may be considered off-label.

**It is crucial to understand that dabrafenib is only effective in cancers with the specific BRAF V600 mutation.  Genetic testing is essential before starting treatment.**


**Side Effects:** Dabrafenib can cause a wide range of side effects, some common and others serious.  Common side effects include:

* **Skin reactions:** Rash, dryness, itching, redness, photosensitivity (increased sensitivity to sunlight).
* **Fatigue:** Feeling tired and weak.
* **Nausea:** Feeling sick to your stomach.
* **Hair thinning:** Hair loss.
* **Muscle pain:** Myalgia.
* **Joint pain:** Arthralgia.
* **Diarrhea:** Loose stools.
* **Fever:** Elevated body temperature.


**Serious side effects are less common but require immediate medical attention. These include:**

* **Cardiovascular problems:**  Such as irregular heartbeats (arrhythmias) or high blood pressure.
* **Eye problems:**  Such as uveitis (inflammation of the eye).
* **Hepatotoxicity (liver damage):** Elevated liver enzymes.
* **Hyperglycemia (high blood sugar):** Especially in patients with a history of diabetes.
* **Keratinization:** Thickening of the skin.
* **Severe skin reactions (such as Stevens-Johnson syndrome or toxic epidermal necrolysis):** These are rare but life-threatening.
* **Tumor growth in the brain:** BRAF inhibitor resistance may lead to increased growth in the brain.


**How it Works:** Dabrafenib is a BRAF inhibitor.  The BRAF gene produces a protein called BRAF kinase, which plays a crucial role in cell growth and division.  In cancers with BRAF V600 mutations, this protein is abnormally active, leading to uncontrolled cell growth. Dabrafenib works by blocking the activity of the mutated BRAF protein, slowing down or stopping the growth of cancer cells.


**FAQs:**

* **Q: How is dabrafenib administered?** A: Dabrafenib is usually taken orally as a tablet.
* **Q: How long is the treatment course?** A: The duration of treatment varies depending on the individual's response to the medication and the type of cancer being treated. It can range from several months to years.
* **Q: What are the drug interactions?** A: Dabrafenib can interact with other medications.  It's vital to inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **Q: What should I do if I experience side effects?** A:  Report any side effects, especially serious ones, to your doctor immediately.  They can help manage your symptoms and adjust your treatment plan as needed.
* **Q: Is dabrafenib a cure for cancer?** A: Dabrafenib is a targeted therapy that can help control cancer growth and improve survival, but it is not a cure.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The side effects and usage information may not be completely exhaustive and can vary based on the individual and their specific health condition.  Always follow the instructions provided by your doctor or pharmacist.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.